Jean Pierre Bizzari Aprea Therapeutics, Inc. (APRE) insider trading activity

Jean Pierre Bizzari is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 1,045 shares of APRE, which is worth approximately $1,881. The most recent transaction as insider was on Jun 05, 2025, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.05K

n/a 3M change

n/a 12M change

Total Value Held $1,881

JEAN-PIERRE BIZZARI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 05 2025	BUY Grant, award, or other acquisition	-	1,045 Added 50.0%	1,045 Common Stock

Also insider at

HALO

HALOZYME THERAPEUTICS, INC. Healthcare

ADCT

ADC Therapeutics SA Healthcare

Director